d'Apice AJ - Search Results

1

The human ICAM-2 promoter is endothelial cell-specific in vitro and in vivo and contains critical Sp1 and GATA binding sites.

Cowan PJ, Tsang D, Pedic CM, Abbott LR, Shinkel TA, d'Apice AJ, Pearse MJ. Cowan PJ, et al. J Biol Chem. 1998 May 8;273(19):11737-44. doi: 10.1074/jbc.273.19.11737. J Biol Chem. 1998. PMID: 9565596 Free article.

2

Towards endothelial cell-specific transgene expression in pigs: characterization of the pig ICAM-2 promoter.

Godwin JW, Fisicaro N, d'Apice AJ, Cowan PJ. Godwin JW, et al. Xenotransplantation. 2006 Nov;13(6):514-21. doi: 10.1111/j.1399-3089.2006.00341.x. Xenotransplantation. 2006. PMID: 17059578

3

Targeting gene expression to endothelium in transgenic animals: a comparison of the human ICAM-2, PECAM-1 and endoglin promoters.

Cowan PJ, Shinkel TA, Fisicaro N, Godwin JW, Bernabéu C, Almendro N, Rius C, Lonie AJ, Nottle MB, Wigley PL, Paizis K, Pearse MJ, d'Apice AJ. Cowan PJ, et al. Xenotransplantation. 2003 May;10(3):223-31. doi: 10.1034/j.1399-3089.2003.01140.x. Xenotransplantation. 2003. PMID: 12694542

4

Targeting gene expression to endothelial cells in transgenic mice using the human intercellular adhesion molecule 2 promoter.

Cowan PJ, Shinkel TA, Witort EJ, Barlow H, Pearse MJ, d'Apice AJ. Cowan PJ, et al. Transplantation. 1996 Jul 27;62(2):155-60. doi: 10.1097/00007890-199607270-00002. Transplantation. 1996. PMID: 8755809

5

Expression and functional analysis of glycosyl-phosphatidyl inositol-linked CD46 in transgenic mice.

Shinkel TA, Cowan PJ, Barlow H, Aminian A, Romanella M, Lublin DM, Pearse MJ, d'Apice AJ. Shinkel TA, et al. Transplantation. 1998 Dec 15;66(11):1401-6. doi: 10.1097/00007890-199812150-00001. Transplantation. 1998. PMID: 9869079

6

Characterization of pig intercellular adhesion molecule-2 and its interaction with human LFA-1.

Godwin JW, d'Apice AJ, Cowan PJ. Godwin JW, et al. Am J Transplant. 2004 Apr;4(4):515-25. doi: 10.1111/j.1600-6143.2004.00369.x. Am J Transplant. 2004. PMID: 15023143 Free article.

7

Expression of functional decay-accelerating factor (CD55) in transgenic mice protects against human complement-mediated attack.

van Denderen BJ, Pearse MJ, Katerelos M, Nottle MB, Du ZT, Aminian A, Adam WR, Shenoy-Scaria A, Lublin DM, Shinkel TA, d'Apice AJ. van Denderen BJ, et al. Transplantation. 1996 Feb 27;61(4):582-8. doi: 10.1097/00007890-199602270-00012. Transplantation. 1996. PMID: 8610385

8

Two genetic approaches to the galactose alpha 1,3 galactose xenoantigen.

d'Apice AJ, Tange MJ, Chen GC, Cowan PJ, Shinkel TA, Pearse MJ. d'Apice AJ, et al. Transplant Proc. 1996 Apr;28(2):540. Transplant Proc. 1996. PMID: 8623255 No abstract available.

9

Decay-accelerating factor transgenic mouse hearts are protected from human complement-mediated attack.

van Denderen BJ, Pearse MJ, Aminian A, Adam W, Shinkel TA, d'Apice AJ. van Denderen BJ, et al. Transplant Proc. 1996 Apr;28(2):583-4. Transplant Proc. 1996. PMID: 8623284 No abstract available.

10

Changes in cell surface glycosylation in alpha1,3-galactosyltransferase knockout and alpha1,2-fucosyltransferase transgenic mice.

Shinkel TA, Chen CG, Salvaris E, Henion TR, Barlow H, Galili U, Pearse MJ, d'Apice AJ. Shinkel TA, et al. Transplantation. 1997 Jul 27;64(2):197-204. doi: 10.1097/00007890-199707270-00003. Transplantation. 1997. PMID: 9256173

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

230 results

Search Page

Filters